Joseph A. Ioppolo
University of Sydney
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joseph A. Ioppolo.
Dalton Transactions | 2014
Christopher J.D. Austin; Jan Kahlert; Fatiah Issa; John H. Reed; Jason R. Smith; Joseph A. Ioppolo; Jennifer Ong; Joanne F. Jamie; David E. Hibbs; Louis M. Rendina
Indoleamine-2,3-dioxygenase-1 (IDO1) is a critical immunoregulatory enzyme responsible for the metabolism of tryptophan during inflammation and disease. Based upon a pyranonaphthoquinone framework, the first examples of indoleamine-2,3-dioxygenase-1 (IDO1) inhibitors containing a carborane cage are reported. The novel closo-1,2-carboranyl-N-pyranonaphthoquinone derivatives display low μM binding affinity for the human recombinant enzyme, with IC50 values ranging from 0.78 to 1.77 μM.
Australian Journal of Chemistry | 2007
Joseph A. Ioppolo; Cameron J. Kepert; David J. Price; Louis M. Rendina
The first examples of gold(i) complexes containing monodentate diphenylphosphine-1,12-carborane and bidentate 1,12-bis(diphenylphosphine)-1,12-carborane ligands are reported.
Chemical Communications | 2013
Joseph A. Ioppolo; Mohan Bhadbhade; Mark A. Fox; Louis M. Rendina
Deboronation and cage rearrangement of the closo-1,12-carborane salt [1,12-(PPh2Me)2-1,12-C2B10H10]I2 occurs in refluxing methanol to give the zwitterionic nido-7,9-carborane 7,9-(PPh2Me)2-7,9-C2B9H9. Notably, deboronation and cage substitution of the isomeric closo-1,7-carborane salt [1,7-(PPh2Me)2-1,7-C2B10H10]I2 takes place in methanol to afford the salt [10-OMe-7,9-(PPh2Me)2-7,9-C2B9H9]I.
Reference Module in Chemistry, Molecular Sciences and Chemical Engineering#R##N#Comprehensive Inorganic Chemistry II (Second Edition)#R##N#From Elements to Applications | 2013
Fatiah Issa; Joseph A. Ioppolo; Louis M. Rendina
This chapter reviews the current state of the art in an experimental cancer treatment known as neutron capture therapy (NCT) with a strong emphasis on the chemistry and biology of selected NCT agents containing boron and/or gadolinium.
Acta Crystallographica Section E-structure Reports Online | 2009
Joseph A. Ioppolo; Jack K. Clegg; Louis M. Rendina
The title compound, [Au(C26H30B10P2)(C26H30B9P2)]·0.5CH2Cl2·0.5H2O, contains two independent complex molecules in the asymmetric unit. The gold(I) centres display a distorted tetrahedral geometry. The complex is stablized through weak intramolecular π–π stacking (Cg⋯Cg = 4.17 Å) and edge-to-face interactions (H⋯Cg = 3.21 Å). Adjacent molecules interact through C—H⋯π (H⋯Cg = 2.88 Å) and B—H⋯π (H⋯Cg = 3.15 Å) contacts, forming a three-dimensional network, with solvent molecules occupying the cavities. One of the phenyl groups was disordered over two sites with occupancy factors of 0.65 and 0.35.
Dalton Transactions | 2007
Joseph A. Ioppolo; Jack K. Clegg; Louis M. Rendina
Tetrahedron Letters | 2009
Joseph A. Ioppolo; Michael Kassiou; Louis M. Rendina
Chemical Communications | 2014
Daniel E. Morrison; Jade B. Aitken; Martin D. de Jonge; Joseph A. Ioppolo; Hugh H. Harris; Louis M. Rendina
Bioinorganic Medicinal Chemistry | 2011
Ellen L. Crossley; H. Y. Vincent Ching; Joseph A. Ioppolo; Louis M. Rendina
Tetrahedron Letters | 2017
Joseph A. Ioppolo; Nicolas Giboureau; Mohan Bhadbhade; Daniel E. Morrison; Michael Kassiou; Louis M. Rendina